OVID
Ovid Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.69
−0.37%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 1469.69x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.50x
- Price / sales
- 331.87x
- Price / cash flow
- -9.59x
Enterprise value
- Enterprise value
- $420.8M
- EV / sales
- 265.85x
- EV / EBITDA
- -11.80x
- EV / EBIT
- -7.21x
- Market cap
- $525.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026